◀ Back to TRIO

RHOG — TRIO

Pathways - manually collected, often from reviews:

• Reactome Reaction: RHOG → TRIO (reaction) Reid et al., J Biol Chem 1999, Schmidt et al., Genes Dev 2002, Jaffe et al., Annu Rev Cell Dev Biol 2005, Ramos-Morales et al., Oncogene 1995, Pasteris et al., Cell 1994, Hart et al., J Biol Chem 1994, Hart et al., J Biol Chem 1996, Zheng et al., J Biol Chem 1996, Van Aelst et al., Genes Dev 1997, Ren et al., J Biol Chem 1998

Text-mined interactions from Literome

Blangy et al., Biol Cell 2006 (Cell Transformation, Neoplastic) : Using the yeast exchange assay, we show that in the presence of TRIO-GEFD1 , RhoG-T17N can bind to its effectors, which illustrates how negative mutants may produce misleading interpretations and emphasizes the need for new types of RhoGEF inhibitors
Kwiatkowska et al., Molecular cancer 2012 (Brain Neoplasms...) : Both Trio and Vav3 act on the small GTPase RhoG